FROG Form 4: Yoav Landman Sells 50k Shares Under 10b5-1 Plan
Rhea-AI Filing Summary
Yoav Landman, JFrog Ltd. Chief Technology Officer and director, reported the sale of 50,000 ordinary shares on 08/22/2025. The sales were executed under a Rule 10b5-1 trading plan adopted August 13, 2024, at prices ranging from $47.00 to $47.48, with a weighted average sale price of $47.11. After the reported transaction, the filing shows the reporting person beneficially owns 6,221,086 shares. The Form 4 was signed on 08/26/2025 by an attorney-in-fact on behalf of the reporting person. The filer offers to provide full details of individual sale prices upon request.
Positive
- Sale executed under a Rule 10b5-1 trading plan, indicating pre-arranged trading and governance controls
- Clear disclosure of weighted average price and price range and an offer to provide per-trade details upon request
- Reporting person retains substantial beneficial ownership after the sale (6,221,086 shares)
Negative
- Insider disposed of 50,000 ordinary shares, reducing direct holdings by that amount
- Form 4 shows an open sale rather than a transfer to lock-up or charitable vehicle (no offsetting acquisition disclosed)
Insights
TL;DR: Insider sale was executed under a pre-established 10b5-1 plan; transaction appears routine and disclosed transparently.
The sale of 50,000 shares at a weighted average price of $47.11 was effected pursuant to a Rule 10b5-1 plan adopted August 13, 2024, which reduces the likelihood the transactions were timed based on material nonpublic information. The post-sale beneficial ownership remains substantial at 6,221,086 shares, indicating continued insider alignment with shareholders. No derivative transactions or additional filings are disclosed. Impact on valuation is likely limited given this single disclosed sale.
TL;DR: Proper form and disclosures were filed; use of a 10b5-1 plan supports governance best practices for insider trades.
The Form 4 documents that the reporting person is both an officer (CTO) and a director and that the sale was conducted under a documented 10b5-1 trading plan, which is consistent with governance protocols to avoid appearance of opportunistic trading. The filer commits to provide detailed per-trade pricing on request, enhancing transparency. There are no indications in this filing of related-party transfers, option exercises, or derivative activity.